Browse 24928 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
March 31st, 2024 |
FY2024 U.S. Consulate General Osaka-Kobe: Games for Social Change Program |
US Mission to Japan |
June 27th, 2024 |
Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes (R01 Clinical trial Required) |
National Institutes of Health |
February 13th, 2024 |
Localization in Health |
Nigeria USAID Abuja |
April 24th, 2024 |
Prevention Technology Transfer Centers Cooperative Agreements |
Substance Abuse and Mental Health Services Adminis |
January 13th, 2027 |
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required) |
National Institutes of Health |
August 14th, 2024 |
Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Basic Experimental Studies with Humans (BESH) Required) |
National Institutes of Health |
January 13th, 2027 |
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required) |
National Institutes of Health |
June 10th, 2024 |
The National Center for Mental Health Dissemination, Implementation and Sustainment Cooperative Agreement |
Substance Abuse and Mental Health Services Adminis |
August 14th, 2024 |
Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trials Not Allowed) |
National Institutes of Health |
May 20th, 2024 |
Promoting the Integration of Primary and Behavioral Health Care: Collaborative Care Model |
Substance Abuse and Mental Health Services Adminis |
August 14th, 2024 |
Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trial Optional) |
National Institutes of Health |
July 25th, 2024 |
Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders (R43/R44 Clinical Trials Not Allowed) |
National Institutes of Health |
July 25th, 2024 |
Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders (R41/R42 Clinical Trials Not Allowed) |
National Institutes of Health |
February 9th, 2024 |
USAID/Kenya and East Africa Global Health Security (GHS) Activity |
Kenya USAID Nairobi |
May 28th, 2024 |
Advancing Diagnostic Network Optimization, Stepwise Laboratory Accreditation, and Integrated One Health Specimen Transport in Liberia |
Centers for Disease Control and Prevention |
January 7th, 2027 |
Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
March 30th, 2024 |
Evaluation and Coordinating Center for the AHRQ/PCORI Learning Health System Embedded Scientist Training and Research Centers (U18) |
Agency for Health Care Research and Quality |
May 31st, 2024 |
Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2027 |
Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed) |
National Institutes of Health |
March 5th, 2024 |
Rehabilitation for Ukraine (Rehab4U) Activity |
Ukraine USAID Kiev |
|
March 22nd, 2024 |
Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2027 |
Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed) |
National Institutes of Health |
March 9th, 2026 |
International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed |
National Institutes of Health |
June 22nd, 2026 |
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional) |
National Institutes of Health |
June 25th, 2026 |
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) |
National Institutes of Health |
June 22nd, 2026 |
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional) |
National Institutes of Health |
June 22nd, 2026 |
Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional) |
National Institutes of Health |
February 22nd, 2024 |
Regional Approaches for Eradicating Tuberculosis (RAFET) |
Kazakhstan USAID Almaty |
April 15th, 2024 |
Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network - 3 (U24 Clinical Trial RequiredInfrastructure) |
National Institutes of Health |
April 15th, 2024 |
Clinical Sites for the Environmental influences on Child Health Outcomes (ECHO) IDeA States Pediatric Clinical Trials Network - 3 (UG1 Clinical Trial Required) |
National Institutes of Health |
November 5th, 2024 |
Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional) |
National Institutes of Health |
April 24th, 2024 |
Public Health Emergency Preparedness (PHEP) Cooperative Agreement |
Centers for Disease Control ORR |
March 9th, 2026 |
International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required) |
National Institutes of Health |
April 12th, 2024 |
Denali Commission Program Grants |
Denali Commission |
February 11th, 2027 |
High Priority HIV and Substance Use Research (RM1 Clinical Trial Optional) |
National Institutes of Health |
April 2nd, 2024 |
NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed) |
National Institutes of Health |
March 1st, 2024 |
Alumni Engagement Innovation Fund FY24 (Sudan) |
US Mission to Sudan |
May 30th, 2024 |
Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult Services (U01 Clinical Trials Optional) |
National Institutes of Health |
May 30th, 2024 |
Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional) |
National Institutes of Health |
May 30th, 2024 |
Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional) |
National Institutes of Health |